Kevin Bernier, director of advocacy relations at Bayer, brings over twenty years of diversified experience directing global, national and regional stakeholder engagement plans and designing strategies for multiple launches. Kevin leads a team focused on all therapeutic areas in the pharmaceutical portfolio, engaging key patient advocates and healthcare policy stakeholders. Kevin’s previous leadership roles were at Gilead Sciences and Pfizer, among others.
4:30 PM - 5:30 PM
Tuesday, June 4
Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned from a Novel Pilot Program
The advent of patient-focused drug development has underscored the priority of engaging the patient…